.png)
Empowering Cancer Care
Proteomica empowers cancer care through its advanced proteomics and multi-omics capabilities, which can be applied to biomarker discovery and personalized medicine. Utilizing technologies such as the state-of-the-art 4D timsTOF Pro 2 mass spectrometer, the company analyzes the protein and metabolite profiles of cancerous tissues and bodily fluids. This comprehensive analysis provides a deeper understanding of tumor biology, identifies specific protein markers for early detection and prognosis, and helps predict a patient's response to targeted therapies. By integrating proteomics with genomics, Proteomica aims to move cancer care beyond a "one-size-fits-all" model towards more effective and individualized treatment strategies.
Maternal and Child Health
Proteomica leverages advanced proteomics and metabolomics to research and enhance maternal and child health. By performing detailed analysis of protein and metabolite profiles, the company aims to gain deep insights into the health and nutritional needs of both mothers and children. This approach is designed to facilitate the early detection of health issues, provide personalized interventions, and enable continuous health monitoring to improve overall well-being and outcomes for mothers and their children.
Proteomica is dedicated to advancing personalized medicine by utilizing advanced proteomics and multi-omics technologies. The company’s approach involves developing “digital health signatures” by analyzing a patient’s unique protein, metabolite, and genetic profiles. This comprehensive analysis helps in early disease detection, identifying molecular drivers of disease, and predicting individual responses to therapies. By translating complex proteomic data into actionable insights, Proteomica helps clinicians create more precise and effective treatment plans tailored to each patient's unique biological makeup, thereby moving healthcare from a "one-size-fits-all" model to a more targeted and effective approach.
Personalized Healthcare
Aging and Wellness
Proteomica utilizes advanced proteomics and multi-omics to study the complex molecular changes associated with aging. By creating "digital health signatures," the company analyzes an individual's unique protein and metabolite profiles to assess biological age and identify pathways related to age-related decline. This data-driven approach helps inform proactive health and wellness strategies, aiming to optimize patient outcomes by delaying or mitigating the onset of age-related diseases. The goal is to provide evidence-based personalized wellness solutions that transition healthcare from a reactive, one-size-fits-all model to a proactive, targeted approach.
